Rheumatoid arthritis (RA) is a chronic, systemic autoimmune disease that primarily affects the joints but can also involve multiple organs. It is characterized by persistent inflammation of the synovial lining of joints, leading to progressive joint damage, deformity, and functional disability if not adequately treated.
What is it
Rheumatoid arthritis is an inflammatory autoimmune disorder in which the immune system mistakenly attacks the synovium—the membrane lining the joints. This results in chronic inflammation, synovial hypertrophy, cartilage destruction, and bone erosion. RA typically affects joints symmetrically, especially the small joints of the hands and feet, and may also cause systemic manifestations.
What causes it
The exact cause of RA is unknown, but it results from an interaction between genetic predisposition and environmental triggers. Genetic factors, such as specific HLA-DRB1 alleles, increase susceptibility. Environmental factors include smoking, infections, and hormonal influences. These triggers activate an abnormal immune response, leading to the production of autoantibodies and inflammatory cytokines that sustain joint inflammation and damage.
What are the symptoms
Symptoms often develop gradually but may begin suddenly in some individuals. Common symptoms include joint pain, swelling, warmth, and stiffness, particularly morning stiffness lasting longer than one hour. RA typically affects joints symmetrically. Systemic symptoms such as fatigue, low-grade fever, weight loss, and malaise are common. As the disease progresses, joint deformities, reduced mobility, and extra-articular manifestations such as rheumatoid nodules, lung involvement, and cardiovascular complications may occur.
How the diagnosis is made
Diagnosis is based on a combination of clinical assessment, laboratory tests, and imaging. Blood tests may reveal elevated inflammatory markers (ESR and CRP), rheumatoid factor (RF), and anti-cyclic citrullinated peptide (anti-CCP) antibodies, which are highly specific for RA. Imaging studies such as X-rays, ultrasound, or MRI help identify joint inflammation and early erosive changes. Classification criteria from the American College of Rheumatology and the European League Against Rheumatism (ACR/EULAR) are commonly used.
Importance of diagnostic tests
Diagnostic tests are essential for confirming RA, differentiating it from other inflammatory arthritides, assessing disease activity, and predicting prognosis. Anti-CCP antibodies, in particular, are associated with more aggressive disease. Imaging helps detect early joint damage that may not be evident on physical examination.
Importance of early diagnosis
Early diagnosis is critical because RA causes irreversible joint damage early in the disease course. Initiating treatment during the “window of opportunity” significantly improves outcomes by reducing disease activity, preventing structural damage, preserving function, and decreasing long-term disability.
Management options
Management of RA aims to achieve disease remission or low disease activity. Treatment includes disease-modifying antirheumatic drugs (DMARDs) such as methotrexate, which are the cornerstone of therapy. Biologic agents and targeted synthetic DMARDs are used in moderate to severe cases. NSAIDs and corticosteroids help control symptoms but do not prevent disease progression. Non-pharmacological management includes physiotherapy, occupational therapy, patient education, and lifestyle modifications.
Prognosis
RA is a chronic, lifelong condition, but advances in early diagnosis and targeted therapy have significantly improved prognosis. Many patients achieve remission or sustained disease control. Without proper treatment, RA can lead to severe disability, reduced quality of life, and increased mortality due to systemic complications.
